KR20010075314A - 급성 통증 치료용 펜타닐 조성물 - Google Patents
급성 통증 치료용 펜타닐 조성물 Download PDFInfo
- Publication number
- KR20010075314A KR20010075314A KR1020017003714A KR20017003714A KR20010075314A KR 20010075314 A KR20010075314 A KR 20010075314A KR 1020017003714 A KR1020017003714 A KR 1020017003714A KR 20017003714 A KR20017003714 A KR 20017003714A KR 20010075314 A KR20010075314 A KR 20010075314A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- fentanyl
- carrier particles
- cellulose
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Physiology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
유 속(㎖/분) | 펜타닐 제거 % | ||
A | B | C | |
>15 | <50 | <50 | >95 |
Claims (20)
- 캐리어 입자의 표면에 점착된 펜타닐 또는 그것의 약제학적으로 수용가능한 염의 미소입자의 수분이 없는 주문된 혼합물을 포함하며, 상기 캐리어 입자는 상기 펜타닐의 미소입자보다 실질적으로 크며 기본적으로 수용성이고 생 점착 및/또는 점막점착 촉진제가 주로 캐리어 입자의 표면에 점착되는 것을 특징으로 하는, 설하 투여에 의해 급성 통증을 치료하기 위한 약제학적 조성물.
- 제 1항에 있어서, 0.05-20중량%의 펜타닐을 포함하는 조성물.
- 제 1항 또는 제 2항에 있어서, 0.05-5중량%, 바람직하게는 0.1-1중량%의 펜타닐을 포함하는 조성물.
- 제 1-3항 중 어느 한 항에 있어서, 펜타닐의 입자가 10㎛이하의 중량에 기초한 평균 직경을 갖는 조성물.
- 제 1-4항 중 어느 한 항에 있어서, 캐리어 입자의 평균 시브 직경이 750㎛이하, 바람직하게는 100-600㎛인 조성물.
- 제 1-5항 중 어느 한 항에 있어서, 캐리어가 압축될 때 쉽게 단편화되는 부서지기 쉬운 물질을 포함하는 조성물.
- 제 1항에 있어서, 캐리어 입자가 총 조성물에 기초하여 0.1-25중량%, 바람직하게는 1-15중량%의 생/점막점착 촉진제를 포함하는 조성물.
- 제 7항에 있어서, 생/점막점착 촉진제가 아크릴성 폴리머, 셀룰로오즈 유도체, 점막점착 특성을 갖는 천연 폴리머 및 이들의 혼합물로 이루어진 그룹으로부터 선택되는 조성물.
- 제 8항에 있어서, 생/점막점착 촉진제가 셀룰로오즈 유도체로 이루어진 그룹으로부터 선택되고, 하이드록시프로필메틸 셀룰로오즈, 하이드록시에틸 셀룰로오즈, 하이드록시프로필 셀룰로오즈, 소듐 카르복시메틸 셀룰로오즈, 메틸 셀룰로오즈, 에틸 하이드록시에틸 셀룰로오즈, 카르복시메틸 셀룰로오즈, 마이크로크리스탈린 셀룰로오즈 및 모디피드 셀룰로오즈 검 ; 크로스카라멜로스 ; 모디피드 스타치 ; 아크릴 폴리머 컴프라이징 카보머 및 데리베이티브 ; 폴리에틸렌 옥사이드 ; 키토산 ; 젤라틴 ; 소듐 알지네이트 ; 펙틴 ; 스클러로글루칸, 잔탄 검 ; 구아 검 ; 폴리-코-(메틸 피닐 에테르-말레익 안하이드라이드) ; 이들의 혼합물을 포함하는 조성물.
- 제 1-9항 중 어느 한 항에 있어서, 펜타닐과 적절하게 혼합된 미세하게 분산된 형태의 약제학적으로 수용가능한 계면활성제를 더 포함하는 조성물.
- 제 10항에 있어서, 계면활성제가 조성물의 0.5-5중량%, 바람직하게는 0.5-3중량%의 양으로 존재하는 조성물.
- 제 10항 또는 제 11항에 있어서, 계면활성제가 소듐라우릴 설페이트, 폴리소르베이트, 담즙산 염 및 이들의 혼합물로 이루어진 그룹으로부터 선택되는 조성물.
- 제 1-12항 중 어느 한 항에 있어서, 캐리어 입자가 수용성의 약제학적으로 수용가능한 카보하이드레이트 및/또는 무기염을 포함하는 조성물.
- 제 13항에 있어서, 캐리어 입자가 만니톨, 락토오즈, 칼슘포스페이트 및 당으로 이루어진 물질 중 하나 이상을 포함하는 조성물.
- 제 1-14항 중 어느 한 항에 있어서, 캐리어 입자가 설하 점막상에서 펜타닐 미소입자의 분산을 촉진시키는, 최소한 하나의 약제학적 붕해제를 함유하는 조성물.
- 제 15항에 있어서, 붕해제가 가교결합된 폴리비닐피롤리돈, 카르복시메틸 전분, 천연전분, 미소결정 셀룰로오즈, 셀룰로오즈 검 및 이들의 혼합물로 이루어진그룹으로부터 선택되는 조성물.
- 제 15항 또는 제 16항에 있어서, 붕해제가 조성물의 1-10중량%의 양으로 존재하는 조성물.
- 미소 입자가 캐리어 입자의 표면에 점착되며, 캐리어 입자는 상기 미소입자보다 실질적으로 크고 기본적으로 수용성이며, 생점착 및/또는 점막점착 촉진제는 주로 캐리어 입자의 표면에 점착되는, 설하 투여에 의해 급성 통증을 치료하기 위한, 기본적으로 수분이 없는 약제학적 조성물을 제조하는데 사용하는, 미소 입자 형태로의 펜타닐 또는 그것의 약제학적으로 수용가능한 염의 용도.
- 급성 통증 치료 방법에 있어서, 펜타닐의 미소입자보다 실질적으로 크며, 기본적으로 수용성이고 생 및/또는 점막점착 촉진제가 그 표면에 점착되는 캐리어 입자의 표면에 점착된 미소 입자 형태의 펜타닐 또는 그것의 약제학적으로 수용가능한 염을 효과적인 양으로 함유하는, 기본적으로 수분이 없는 약제학적 조성물을 최소한 하나의 복용량 단위로 급성통증에 시달리는 환자에게 설하투여 하는 것을 특징으로 하는 급성통증치료 방법.
- 제 19항에 있어서, 펜타닐이 복용량 단위당 0.05-20mg, 바람직하게는 0.1-5mg의 양으로 투여되는 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803239-4 | 1998-09-24 | ||
SE9803239A SE9803239D0 (sv) | 1998-09-24 | 1998-09-24 | Composition for the treatment of acute pain |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010075314A true KR20010075314A (ko) | 2001-08-09 |
KR100760531B1 KR100760531B1 (ko) | 2007-10-04 |
Family
ID=20412701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020017003714A KR100760531B1 (ko) | 1998-09-24 | 1999-09-24 | 급성 통증 치료용 펜타닐 조성물 |
Country Status (26)
Country | Link |
---|---|
US (1) | US6759059B1 (ko) |
EP (1) | EP1115384B1 (ko) |
JP (2) | JP2002526440A (ko) |
KR (1) | KR100760531B1 (ko) |
CN (1) | CN1170524C (ko) |
AT (1) | ATE247950T1 (ko) |
AU (1) | AU764473B2 (ko) |
BG (1) | BG65363B1 (ko) |
BR (1) | BR9913948B1 (ko) |
CA (1) | CA2345064C (ko) |
CZ (1) | CZ301562B6 (ko) |
DE (1) | DE69910803T2 (ko) |
DK (1) | DK1115384T3 (ko) |
EE (1) | EE200100176A (ko) |
ES (1) | ES2207295T3 (ko) |
HU (2) | HU228992B1 (ko) |
IL (2) | IL142126A0 (ko) |
NO (1) | NO332228B1 (ko) |
NZ (1) | NZ510646A (ko) |
PL (1) | PL197078B1 (ko) |
PT (1) | PT1115384E (ko) |
RU (1) | RU2232580C2 (ko) |
SE (1) | SE9803239D0 (ko) |
SK (1) | SK283503B6 (ko) |
TR (1) | TR200100812T2 (ko) |
WO (1) | WO2000016751A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101406918B1 (ko) * | 2006-06-09 | 2014-06-19 | 에씨팜 | 아편계 진통제의 저 용량 설하정 및 제조 프로세스 |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974590B2 (en) | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US20030091629A1 (en) * | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
SE9803240D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
BRPI0015284B8 (pt) | 1999-10-29 | 2021-05-25 | Euro Celtique S/A | formulações de hidrocodona de liberação controlada |
IT1318618B1 (it) * | 2000-07-10 | 2003-08-27 | A C R Applied Coating Res S A | Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi. |
DE20122843U1 (de) | 2000-07-31 | 2008-06-26 | Nycomed Danmark Aps | Fentanyl Zusammensetzung zur nasalen Anwendung |
KR101045144B1 (ko) | 2000-10-30 | 2011-06-30 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
WO2003002071A2 (en) * | 2001-06-29 | 2003-01-09 | Lewandowski Leon J | Individualized addiction cessation therapy |
FR2827517B1 (fr) * | 2001-07-23 | 2003-10-24 | Bioalliance Pharma | Systemes therapeutiques bioadhesifs a liberation prolongee |
DE60219124T2 (de) * | 2001-11-16 | 2008-01-31 | Randox Laboratories Ltd., Crumlin | Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga |
GB0217056D0 (en) * | 2002-07-23 | 2002-08-28 | Ass Octel | Use |
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
CN100581586C (zh) * | 2003-01-31 | 2010-01-20 | 奥雷克索公司 | 一种快速起效的药物组合物 |
AU2004218876B2 (en) * | 2003-03-11 | 2007-08-02 | Arakis Ltd. | Novel compositions containing fentanyl |
JP5137286B2 (ja) | 2003-06-10 | 2013-02-06 | 帝國製薬株式会社 | フェンタニル含有口腔粘膜貼付剤 |
GB0315632D0 (en) | 2003-07-04 | 2003-08-13 | West Pharm Serv Drug Res Ltd | Pharmaceutical formulations |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
JP2007517054A (ja) * | 2003-12-31 | 2007-06-28 | シーマ・ラブス、インコーポレイテッド | 概して線状の発泡性経口フェンタニル投薬形態および投与方法 |
BRPI0418213A (pt) * | 2003-12-31 | 2007-04-27 | Cima Labs Inc | forma de dosagem, e, método para tratar dor em um paciente em necessidade do mesmo |
US7858121B2 (en) | 2003-12-31 | 2010-12-28 | Cima Labs, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
KR20130006523A (ko) * | 2004-02-17 | 2013-01-16 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법 |
GB0423800D0 (en) | 2004-10-27 | 2004-12-01 | Orexo Ab | New pharmaceutical formulations |
FR2883179B1 (fr) | 2005-03-18 | 2009-04-17 | Ethypharm Sa | Comprime enrobe |
CN101151021A (zh) * | 2005-03-28 | 2008-03-26 | 奥瑞克索股份公司 | 用于疼痛治疗的新药物组合物 |
US20070287740A1 (en) * | 2005-05-25 | 2007-12-13 | Transcept Pharmaceuticals, Inc. | Compositions and methods of treating middle-of-the night insomnia |
KR20130042041A (ko) * | 2005-05-25 | 2013-04-25 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | 야반 불면증을 치료하기 위한 고체 조성물 및 방법 |
US20070225322A1 (en) * | 2005-05-25 | 2007-09-27 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the night insomnia |
US9522188B2 (en) * | 2005-12-13 | 2016-12-20 | Biodelivery Sciences International, Inc. | Abuse resistant transmucosal drug delivery device |
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US8252328B2 (en) * | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9066847B2 (en) * | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
CN101495080B (zh) * | 2006-01-06 | 2013-10-23 | 阿塞尔Rx制药有限公司 | 药物存储及发放装置以及包括该装置的系统 |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8252329B2 (en) * | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
NZ569949A (en) | 2006-01-25 | 2011-10-28 | Insys Therapeutics Inc | Sublingual fentanyl spray |
EP1837020A1 (en) | 2006-03-24 | 2007-09-26 | Bioalliance Pharma | Mucosal bioadhesive slow release carrier for delivering active principles |
US20070260491A1 (en) * | 2006-05-08 | 2007-11-08 | Pamela Palmer | System for delivery and monitoring of administration of controlled substances |
US20080069891A1 (en) * | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
US20070299687A1 (en) * | 2006-06-23 | 2007-12-27 | Pamela Palmer | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed |
DK2054031T3 (en) | 2006-07-21 | 2016-05-17 | Biodelivery Sciences Int Inc | Transmucosal delivery devices with improved uptake |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
US20080090874A1 (en) * | 2006-09-20 | 2008-04-17 | Messina John C Jr | Treatment of breakthrough pain in patients suffering from chronic low back pain |
FR2907680B1 (fr) * | 2006-10-27 | 2012-12-28 | Scras | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
EP2101740B1 (en) * | 2006-12-04 | 2013-11-06 | Orexo AB | New non-abusable pharmaceutical composition comprising opioids |
JP2010518086A (ja) | 2007-02-09 | 2010-05-27 | デュレクト コーポレーション | スフェンタニルおよびナロキソンを含む経口腔投与製剤 |
US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
US20080287494A1 (en) * | 2007-04-24 | 2008-11-20 | Cephalon, Inc. | Transmucosal treatment methods in patients with mucositis |
CN101686931B (zh) * | 2007-06-06 | 2013-06-19 | 巴斯夫欧洲公司 | 用于制备可咀嚼片剂和锭剂的药物配制剂 |
PL2180844T3 (pl) | 2007-08-02 | 2018-07-31 | Insys Development Company, Inc. | Rozpylacz podjęzykowy z fentanylem |
US8945592B2 (en) | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
EP2295046B1 (de) * | 2009-09-14 | 2012-12-19 | Acino AG | Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon |
EP2488029B1 (en) | 2009-09-30 | 2016-03-23 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
PL3254676T3 (pl) | 2009-10-30 | 2019-06-28 | Ix Biopharma Ltd | Szybko rozpuszczająca się stała postać dawkowana |
WO2011143120A1 (en) | 2010-05-11 | 2011-11-17 | Cima Labs Inc. | Alcoholres i stant metoprolol - containing extended - release oral dosage forms |
US20120183580A1 (en) * | 2011-01-13 | 2012-07-19 | Theralpha | Analgesic Composition for Transbuccal Administration |
US8703177B2 (en) | 2011-08-18 | 2014-04-22 | Biodelivery Sciences International, Inc. | Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
JP6210988B2 (ja) | 2011-09-19 | 2017-10-11 | オレクソ・アクチエボラゲット | オピオイド依存を治療するための新規乱用耐性医薬組成物 |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
DE102012006396A1 (de) | 2012-03-29 | 2013-10-02 | Willy Rüsch GmbH | Tracheostomietubus |
SG11201407081PA (en) | 2012-05-02 | 2014-11-27 | Orexo Ab | New alfentanil composition for the treatment of acute pain |
CN104968333B (zh) | 2012-11-30 | 2018-07-10 | 阿库拉制药公司 | 活性药物成分的自调节释放 |
US20150118300A1 (en) | 2013-10-31 | 2015-04-30 | Cima Labs Inc. | Immediate Release Abuse-Deterrent Granulated Dosage Forms |
CN115671064A (zh) * | 2014-02-07 | 2023-02-03 | 讯唐制药公司 | 全天然无毒舌下药物递送系统 |
WO2016086095A1 (en) | 2014-11-25 | 2016-06-02 | Biodelivery Sciences International, Inc. | Patches, methods for forming and testing pharmaceutical agent delivery patches |
WO2017040607A1 (en) | 2015-08-31 | 2017-03-09 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US11324707B2 (en) | 2019-05-07 | 2022-05-10 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
US20220062200A1 (en) | 2019-05-07 | 2022-03-03 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8332556D0 (en) * | 1983-12-06 | 1984-01-11 | Reckitt & Colmann Prod Ltd | Analgesic compositions |
US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
SE8800080L (sv) * | 1988-01-13 | 1989-07-14 | Kabivitrum Ab | Laekemedelskomposition |
JP3836566B2 (ja) * | 1996-05-13 | 2006-10-25 | 久光製薬株式会社 | フェンタニル含有経皮投与テープ製剤 |
JP3943724B2 (ja) * | 1998-07-31 | 2007-07-11 | 東光薬品工業株式会社 | フェンタニル含有経皮投与マトリックス型貼付剤 |
SE9803240D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
-
1998
- 1998-09-24 SE SE9803239A patent/SE9803239D0/xx unknown
-
1999
- 1999-09-24 WO PCT/SE1999/001688 patent/WO2000016751A1/en active IP Right Grant
- 1999-09-24 US US09/787,887 patent/US6759059B1/en not_active Expired - Lifetime
- 1999-09-24 ES ES99952868T patent/ES2207295T3/es not_active Expired - Lifetime
- 1999-09-24 EP EP99952868A patent/EP1115384B1/en not_active Expired - Lifetime
- 1999-09-24 PT PT99952868T patent/PT1115384E/pt unknown
- 1999-09-24 EE EEP200100176A patent/EE200100176A/xx unknown
- 1999-09-24 KR KR1020017003714A patent/KR100760531B1/ko active IP Right Grant
- 1999-09-24 NZ NZ510646A patent/NZ510646A/en not_active IP Right Cessation
- 1999-09-24 JP JP2000573712A patent/JP2002526440A/ja not_active Withdrawn
- 1999-09-24 BR BRPI9913948-0A patent/BR9913948B1/pt not_active IP Right Cessation
- 1999-09-24 CN CNB998136220A patent/CN1170524C/zh not_active Expired - Fee Related
- 1999-09-24 IL IL14212699A patent/IL142126A0/xx active IP Right Grant
- 1999-09-24 CA CA002345064A patent/CA2345064C/en not_active Expired - Lifetime
- 1999-09-24 DK DK99952868T patent/DK1115384T3/da active
- 1999-09-24 HU HU0103621A patent/HU228992B1/hu unknown
- 1999-09-24 SK SK401-2001A patent/SK283503B6/sk not_active IP Right Cessation
- 1999-09-24 CZ CZ20011030A patent/CZ301562B6/cs not_active IP Right Cessation
- 1999-09-24 RU RU2001111026/15A patent/RU2232580C2/ru active
- 1999-09-24 PL PL347467A patent/PL197078B1/pl unknown
- 1999-09-24 AU AU64928/99A patent/AU764473B2/en active Active
- 1999-09-24 DE DE69910803T patent/DE69910803T2/de not_active Expired - Lifetime
- 1999-09-24 AT AT99952868T patent/ATE247950T1/de active
- 1999-09-24 HU HU1300339A patent/HU230688B1/hu unknown
- 1999-09-24 TR TR2001/00812T patent/TR200100812T2/xx unknown
-
2001
- 2001-03-20 IL IL142126A patent/IL142126A/en not_active IP Right Cessation
- 2001-03-23 NO NO20011502A patent/NO332228B1/no not_active IP Right Cessation
- 2001-03-23 BG BG105380A patent/BG65363B1/bg unknown
-
2004
- 2004-06-04 JP JP2004167572A patent/JP4478512B2/ja not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101406918B1 (ko) * | 2006-06-09 | 2014-06-19 | 에씨팜 | 아편계 진통제의 저 용량 설하정 및 제조 프로세스 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100760531B1 (ko) | 급성 통증 치료용 펜타닐 조성물 | |
KR100760536B1 (ko) | 급성 장해 치료용 약제학적 조성물 | |
MXPA01003063A (en) | Fentanyl composition for the treatment of acute pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
FPAY | Annual fee payment |
Payment date: 20120906 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20130904 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140912 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150902 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160831 Year of fee payment: 10 |
|
J206 | Request for trial to confirm the scope of a patent right | ||
FPAY | Annual fee payment |
Payment date: 20170807 Year of fee payment: 11 |
|
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2016100003416; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161028 Effective date: 20170912 |
|
J302 | Written judgement (patent court) |
Free format text: TRIAL NUMBER: 2017200007739; JUDGMENT (PATENT COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20171113 Effective date: 20180629 |
|
FPAY | Annual fee payment |
Payment date: 20180830 Year of fee payment: 12 |